All In MedTech

Device Trial Radar · NCT01692405

Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample

Last checked: Nov 20, 2026Latest source record: Apr 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 436 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

436

Actual

Start

Apr 29, 2013

Primary completion

Apr 5, 2017

Study completion Apr 24, 2017

Sponsor

Lead sponsor
UC Care, Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Sep 25, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Performance evaluation of a novel, semi-automated device and method for needle core biopsy download compared to standard methods in terms of: 1. Biopsy core length obtained (i.e. collecting all tissue fragments) 2. Biopsy core yield (i.e. percent of tissue loss during the pathologic processing) 3. Pathologist interpretability 4. Processing time 5. Prostate cancer detection.

Conditions

  • Prostate Cancer

Interventions

  • NaviGo Bx™Device

    The NaviGoBx™ system is a device and method that enables an accurate reporting of the exact longitudinal location and direction of the biopsy specimen along the needle notch as well as the accurate length of the specimen. Acquiring this information during the biopsy extraction session provides an accurate designation of the location of any later region of interest within the specimen itself to the longitudinal position along the needle mandrel.

  • biopsy sponge padProcedure

    the biopsy core is downloaded onto a biopsy sponge pad which is than entered into a biopsy cassette.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. percent of tissue lossTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Haemek madical center

    Afula, Israel

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.